Description: Renal disease is a very heterogenous medical condition whose end state is dialysis, a recurring cost intensive medical condition. Dialysis cost is one of the major medical cost drivers in USA. Insufficient and improper care management in the early stages of CKD (chronic kidney disease) leads to early incidence of end stage renal disease (ESRD) among CKD patients which not only leads to high medical costs, but also reflects poor health quality.

Description: The document is about the post-wildfire drinking water crisis and its implications for the insurance industry. It discusses the contamination of drinking water systems by wildfires, remediation strategies, financial considerations for the insurance industry, and potential contributions from the actuarial community.

Description: Come discuss how to treat experience that is impacted by COVID (e.g., 2020+), as well as expected experience moving forward in terms of excess deaths related to COVID and non-COVID topics. Expect to also cover how the COVID period has impacted lapse/surrender behavior and trends in recent industry mortality and lapse studies that have been conducted including areas where individual companies typically have limited data. You will learn about various techniques of adjusting experience for the impact of COVID and the considerations in using such experience and setting a best-estimate assumption going forward. For mortality, the discussion will include both base mortality as well as future mortality improvement and the intersection of both of these.Explore an understanding of available data to supplement their experience in areas where they may have limited internal experience

Description: One common barrier to employing GLM modeling is the lack of sufficient data. This limitation often comes from the combination of the considerations in ASOP No. 25 “Credibility Procedures” and the fact that GLMs assign full credibility to the data. Explore the possibilities of credibility-based regression by expanding the intended purpose of modeling analysis from producing a single model as output to producing data insights, credible differences, and a range of reasonable models.

Description: Dive into the approach and adverse effects of the regulation of 3rd parties and advance consent by the proposed NAIC Consumer Privacy Protection Model Law #674. The regulation of 3rd parties through their contracts with insurers will be explained. Specifics will be provided on the negative effect on companies contracting with 3rd parties. The requirement for advance consent for use of personal data for actuarial and marketing studies will be explained, and two potential solutions will be presented.

Description: The Society of Actuaries Research Institute (SOA) and LIMRA are soliciting surrender and lapse experience for individual Term and Whole Life policies for calendar years 2015 through 2022 to be used to complete a 2015-2022 Term and Whole Life Lapse and Surrender Experience Study (Study).

Description: CMS has required hospitals to publish their chargemaster rates, cash discounts and negotiated rates as of January 1, 2021. Our panel is comprised of a data strategist, an executive from a large hospital system and an actuary.